Plain-English translation of NCT06546345 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This trial is following patients who are receiving a KeriFlex® silicone joint implant to replace damaged finger joints caused by arthritis. Researchers want to understand how well this implant performs and whether it remains safe over time for people with rheumatoid arthritis, osteoarthritis, or arthritis from old injuries.
Even though this implant is already available for use, the manufacturer wants to gather real-world evidence about how it works in patients over both the short and long term to ensure it continues to be safe and effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo surgery to implant the KeriFlex® device in your finger joint and then be followed by the research team to monitor how well it works and whether any complications develop. The study will track your progress both in the short term and over the longer lifespan of the implant to build a complete picture of its safety and performance.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France
Sponsor
Keri Medical SA
Enrollment target
~86 participants
Started
November 2023
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
CAUX
Keri Medical SA
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.